On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of ...

Anthony Bergmann; Chief Financial Officer; Capricor Therapeutics Inc. Linda Marban; President, Chief Executive Officer, Director; Capricor Therapeutics Inc. Edward T ...

A new study published in The Journal of Immunology found that a high-salt diet (HSD) induces depression-like symptoms in mice by driving the production of a protein called IL-17A. This work supports ...

Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...

and thank you for joining Sarepta Therapeutics’ fourth quarter and full year 2024 financial results conference call. As you may know, back in late 2017, we created an expansive strategic plan ...

The HeartMate 3™ LVAD is the most advanced LVAD yet and the only one currently available in the United ... Cadrenal building build a pipeline of specialized cardiovascular therapeutics and ...

Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics Year End 2024 ... We are truly building something special and I strongly believe we have put ourselves in a position ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet need ...

How continent is navigating decades-old obstacles to build robust vaccine industry ANALYSIS | The African Union has embarked ...

Samsung Biologics CEO John Lim reveals 5th factory completion plans for next month Joonrim Samba expands global presence with ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), JPMorgan Chase ...